Daily Roundup

AHC.ASX CCA.ASX SNL.ASX IRI.ASX MVP.ASX

Austco Healthcare Locks in A$4.2m Decade-Long Contract

Austco Healthcare has secured a substantial ten-year maintenance contract with Singapore's Jurong Health Complex, valued at approximately A$4.2 million. The deal, which kicks off on October 1, 2026, covers maintenance services for the company's Tacera Clinical Care Communications solution across the Jurong Health Complex, which encompasses both the Ng Teng Fong General Hospital and Jurong Community Hospital. This extension of their existing relationship provides long-term revenue visibility and aligns with Austco's broader strategy to build predictable recurring revenue streams alongside project sales.

Change Financial Delivers Solid Growth Momentum

Change Financial wrapped up FY26 on a strong note, posting positive net cash flow from operations of US$0.6 million in the final quarter. Full-year revenue climbed 21% to US$18.2 million, with Q4 alone reaching US$4.6 million—up 16% year-over-year. The real standout has been the company's Platform-as-a-Service business, which now boasts over 150,000 active cards, representing a staggering 104% year-over-year jump. Gross margins expanded by 600 basis points across the year, reflecting the benefits of scaling operations. Looking ahead, the company expects FY27 growth to be driven by its PaaS and PaySim businesses, with a particular focus on migrating on-premises clients to the cloud version of Vertexon.

Supply Network Navigates Headwinds While Building for Growth

Supply Network faced some operational turbulence in FY2026, with Middle East hostilities creating cost and sourcing pressures for diesel and lubricants. Despite these challenges, the company continued adding new customers and expanding relationships with existing ones. The firm made significant investments across its network, opening a new branch in Rosedale, New Zealand, and expanding its Hamilton distribution center. In Australia, major IT system upgrades were completed and distribution center integration finalized. The company is gearing up for further expansion, including tripling capacity at the Eagle Farm branch and relocating its Toowoomba operations.

On the financial front, Supply Network reported consolidated sales revenue of $403.1 million and profit after tax of $47.7 million for the year ended June 30, 2026. The board has declared a final fully franked dividend of 44.0 cents per share—up 6.0 cents from the prior year—with a record date of September 18, 2026, and payment on October 2, 2026. For FY2027, the company is targeting revenue growth of around $50 million, leveraging its modernized and scalable systems infrastructure.

Integrated Research Focuses on Product-Led Growth

Integrated Research faced headwinds in FY26, with revenue declining 17% to A$56-58 million, weighed down by a softer renewals book and lower new business in the second half. Pro forma revenue fell 13% to A$64-66 million. EBITDA was modestly improved in the second half but took hits from expected credit losses and foreign exchange movements, landing in the range of (2.0)-(4.0) million. The bright spot came from cash generation, which surged 27% to A$51.7 million. CEO Ian Lowe is now zeroing in on accelerating product monetization and client-led innovation for FY27, positioning the company to leverage its standing as a trusted partner to leading global organizations.

Medical Developments Posts Penthrox Momentum

Medical Developments International delivered positive free cashflow for both Q4 and the full FY26 year. Penthrox revenue jumped $5.4 million for the full year, with particularly strong volume growth of 28% in the Australian hospital segment and 18% in European markets. A major milestone came with the approval and launch of a paediatric label for Penthrox in the UK and all European markets, significantly broadening the product's addressable market. The company's cash balance stood at $21.4 million at June 30, 2026. CEO Brent MacGregor emphasized the company's dual focus on growing Penthrox volume while improving margins and reducing overheads, with expectations for FY26 EBIT to be modestly improved on the prior year.